MIDLAND, Mich., Jan. 23, 2017 -- Chemical Financial Corporation today announced that Jeffrey L. Tate, Corporate Auditor for The Dow Chemical Company, was appointed to the Board of Directors of Chemical Financial Corporation (Nasdaq:CHFC). His appointment, which is effective March 1, 2017, increases the Board to 13 members.
“We are very pleased to welcome Jeff to the Chemical Financial board. His business expertise, extensive knowledge of risk management including financial and operating controls and his demonstrated community leadership will be a tremendous asset to our Company,” said Gary Torgow, Chairman of Chemical Financial Corporation.
Mr. Tate began his Dow career in Louisiana in 1992 and held a variety of accounting and controller roles before relocating to Michigan for several finance and leadership assignments in Dow Automotive, Investor Relations, Performance Materials and Performance Plastics. He is a Certified Public Accountant and serves on the Public Company Accounting Oversight Board’s (PCAOB) Standing Advisory Group and the Corporate Advisory Boards of both Consortium and NABA. He also serves in his community on the Midland Community Center Operating Board.
Mr. Tate earned a Bachelor’s degree in Accounting from the University of Alabama. He also completed various executive education programs, including the American Graduate School of International Management at Thunderbird, the Dartmouth College Strategic Finance Leadership Executive Program, and the University of Chicago Booth School of Business Executive Program for Prospective CFOs.
Chemical Financial Corporation is the largest banking company headquartered and operating branch offices in Michigan. The Corporation operates through its subsidiary bank, Chemical Bank, with 249 banking offices located in Michigan, northeast Ohio and northern Indiana. At September 30, 2016, the Corporation had total assets of $17.4 billion. Chemical Financial Corporation’s common stock trades on The NASDAQ Stock Market under the symbol CHFC and is one of the issuers comprising The NASDAQ Global Select Market and the S&P MidCap 400 Index. More information about the Corporation is available by visiting the “Investor Info” section of its website at www.chemicalbank.com.
For further information: David B. Ramaker, CEO 989-839-5350


TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Samsung Electronics Shares Jump on HBM4 Mass Production Report
Anta Sports Expands Global Footprint With Strategic Puma Stake
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



